YACHMETZ PHILIP K 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Feb 6, 2013
Insider Transaction Report
Form 4
YACHMETZ PHILIP K
SVP, General Counsel
Transactions
- Sale
Common Stock $.01 par value per share
2013-02-04$1.02/sh−3,203$3,267→ 303,701 total - Sale
Common Stock $.01 par value per share
2013-02-04$1.01/sh−27,297$27,570→ 306,904 total
Footnotes (1)
- [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 1, 2012 and February 27, 2012.